After months of deliberation, the World Health Organization finally declares that medical marijuana has no public health risks and should not be withheld from patients.
In a report published recently, the public health wing of the United Nations finally announces that cannabidiol (CBD), the non-psychoactive element in cannabis, should not be a scheduled drug. Following the interest of many of the UN’s member states in the use of cannabis for medical indications, including palliative care, the organization conducted an investigation and gathered “more robust scientific evidence on the therapeutic use and side effects of cannabis and cannabis components.” Based on these studies, they were able to conclude that cannabis has potential therapeutic value for relieving seizures due to epilepsy and other conditions.
The authors also added that this information does not fall in sync with the scheduling of CBD and declared that medical marijuana use does not lead to THC addiction. THC is the psychoactive component in cannabis that induces a high.
The body’s decision marked a new victory for marijuana advocates internationally, especially now that many countries are pushing for their own laws on cannabis.
In the United States, the federal government remains unwavered in its stance to keep marijuana as a Schedule I substance, a category that defines the drug as having absolutely no medical value and high potential for abuse.
How the WHO’s move will affect ongoing movements for legalization in the US and whether Sessions continues to hold up his position on the issue remains to be seen.